EGFR Mutation Testing Practices within the Asia Pacific Region: Results of a Multicenter Diagnostic Survey

INTRODUCTION: The efficacy of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors in EGFR mutation-positive non–small-cell lung cancer (NSCLC) patients necessitates accurate, timely testing. Although EGFR mutation testing has been adopted by many laboratories in Asia, data are lacking...

Descripción completa

Detalles Bibliográficos
Autores principales: Yatabe, Yasushi, Kerr, Keith M., Utomo, Ahmad, Rajadurai, Pathmanathan, Tran, Van Khanh, Du, Xiang, Chou, Teh-Ying, Enriquez, Ma. Luisa D., Lee, Geon Kook, Iqbal, Jabed, Shuangshoti, Shanop, Chung, Jin-Haeng, Hagiwara, Koichi, Liang, Zhiyong, Normanno, Nicola, Park, Keunchil, Toyooka, Shinichi, Tsai, Chun-Ming, Waring, Paul, Zhang, Li, McCormack, Rose, Ratcliffe, Marianne, Itoh, Yohji, Sugeno, Masatoshi, Mok, Tony
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2015
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4342317/
https://www.ncbi.nlm.nih.gov/pubmed/25376513
http://dx.doi.org/10.1097/JTO.0000000000000422

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4342317/
https://www.ncbi.nlm.nih.gov/pubmed/25376513
http://dx.doi.org/10.1097/JTO.0000000000000422

Ejemplares similares